Published in Nephrol Dial Transplant on May 14, 2010
ABO-incompatible renal transplantation: From saline flushes to antigen-specific immunoadsorption-Tools to overcome the barrier. Korean J Hematol (2011) 0.83
Rational clinical trial design for antibody mediated renal allograft injury. Front Biosci (Landmark Ed) (2015) 0.75
Antibody-Mediated Rejection: A Review. Ochsner J (2017) 0.75
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. J Am Soc Nephrol (2005) 2.00
Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts. Crit Care (2012) 1.90
Low but sustained coagulation activation ameliorates glucose-induced podocyte apoptosis: protective effect of factor V Leiden in diabetic nephropathy. Blood (2011) 1.83
Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell (2008) 1.81
Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol (2013) 1.78
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol (2005) 1.74
Clinical value of automatic reporting of estimated glomerular filtration rate in geriatrics. Gerontology (2008) 1.54
Malignancy in renal transplantation. J Am Soc Nephrol (2004) 1.50
Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy. Transpl Int (2012) 1.47
C. elegans as model for the study of high glucose- mediated life span reduction. Diabetes (2009) 1.45
Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients. J Hypertens (2008) 1.42
The influence of haemodialysis on haemodynamic measurements using transpulmonary thermodilution in patients with septic shock: an observational study. Eur J Anaesthesiol (2013) 1.40
Acute phase reaction to gadolinium-DTPA in dialysis patients. Nephrol Dial Transplant (2008) 1.39
Experiences with rituximab for the treatment of autoimmune diseases with ocular involvement. J Rheumatol (2013) 1.39
Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial. Am J Kidney Dis (2011) 1.27
Activation of tubular epithelial cells in diabetic nephropathy. Diabetes (2002) 1.24
Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes. Blood (2011) 1.17
Sirolimus in renal transplantation. Nephrol Dial Transplant (2007) 1.15
Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc. Proc Natl Acad Sci U S A (2012) 1.11
Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid. Mol Cancer Ther (2008) 1.09
Antifibrotic actions of mycophenolic acid. Clin Transplant (2006) 1.08
Do AV fistulas contribute to cardiac mortality in hemodialysis patients? Semin Dial (2002) 1.08
Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products. J Am Soc Nephrol (2005) 1.07
Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int (2003) 1.06
Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers. Transplantation (2015) 1.05
No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol (2006) 1.05
Retinoid receptor-specific agonists alleviate experimental glomerulonephritis. Am J Physiol Renal Physiol (2002) 1.04
Effects of peritoneal dialysis solutions low in GDPs on peritonitis and exit-site infection rates. Perit Dial Int (2008) 1.00
Color doppler ultrasonography in the diagnostic evaluation of renal allografts. Nephron Clin Pract (2006) 0.96
Kidney transplantation across HLA and ABO antibody barriers. Curr Opin Organ Transplant (2013) 0.96
Late referral--a major cause of poor outcome in the very elderly dialysis patient. Nephrol Dial Transplant (2006) 0.95
Pharmacokinetics of linezolid in septic patients with and without extended dialysis. Eur J Clin Pharmacol (2009) 0.92
Cyclosporin A toxicity of the renal allograft--a late complication and potentially reversible. Nephron (2002) 0.90
Aquaporin-1 channel function is positively regulated by protein kinase C. J Biol Chem (2007) 0.89
ABO-incompatible kidney transplantation enabled by non-antigen-specific immunoadsorption. Transplantation (2012) 0.89
Glucose degradation products result in cardiovascular toxicity in a rat model of renal failure. Perit Dial Int (2010) 0.89
An integrative approach for the transplantation of high-risk sensitized patients. Transplantation (2010) 0.88
Nanotube action between human mesothelial cells reveals novel aspects of inflammatory responses. PLoS One (2011) 0.87
Real-time contrast-enhanced sonography in renal transplant recipients. Clin Transplant (2006) 0.86
Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis. J Am Soc Nephrol (2011) 0.86
Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function. Nephrol Dial Transplant (2007) 0.86
Salt--a potential 'uremic toxin'? Blood Purif (2006) 0.86
Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus. Arthritis Rheumatol (2014) 0.86
Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients. Br J Clin Pharmacol (2010) 0.86
The long-term consequences of living-related or unrelated kidney donation. Nephrol Dial Transplant (2004) 0.86
Bleeding complications in pediatric ABO-incompatible kidney transplantation. Pediatr Nephrol (2012) 0.86
Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. Am J Ther (2013) 0.85
Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure. J Am Soc Nephrol (2002) 0.85
RAGE expression in the human peritoneal membrane. Nephrol Dial Transplant (2008) 0.85
Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil. Rheumatology (Oxford) (2010) 0.84
Lifestyle modification and progressive renal failure. Nephrology (Carlton) (2005) 0.84
How should we manage anaemia in patients with diabetes? Nephrol Dial Transplant (2002) 0.84
Role and Value of Luminex(®)-Detected HLA Antibodies before and after Kidney Transplantation. Transfus Med Hemother (2013) 0.83
Procalcitonin as marker of infection in patients with Goodpasture's syndrome is misleading. Nephrol Dial Transplant (2007) 0.83
Uremia aggravates left ventricular remodeling after myocardial infarction. Am J Nephrol (2010) 0.82
Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing. Transplantation (2015) 0.82
Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T. Nephron Clin Pract (2007) 0.82
Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption. Transplantation (2015) 0.82
Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis. Atheroscler Suppl (2013) 0.81
A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function. Clin Chem Lab Med (2016) 0.81
Protocol biopsy: what is the rationale and what is the evidence? Nephrol Dial Transplant (2003) 0.81
Human RAGE antibody protects against AGE-mediated podocyte dysfunction. Nephrol Dial Transplant (2012) 0.81
Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft. Clin J Am Soc Nephrol (2010) 0.81
Chronic low-dose isotretinoin treatment limits renal damage in subtotally nephrectomized rats. J Mol Med (Berl) (2008) 0.81
Good MRI images: to Gad or not to Gad? Pediatr Nephrol (2007) 0.81
Acute effects of calcineurin inhibitors on kidney allograft microperfusion visualized by contrast-enhanced sonography. Transplantation (2012) 0.80
Cellular effects of everolimus and sirolimus on podocytes. PLoS One (2013) 0.80
Contrast enhanced sonography shows superior microvascular renal allograft perfusion in patients switched from cyclosporine A to everolimus. Transplantation (2009) 0.80
Dual regulation of renal Kir7.1 potassium channels by protein Kinase A and protein Kinase C. Biochem Biophys Res Commun (2008) 0.80
An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients. Nephrol Dial Transplant (2005) 0.79
Effect of insulin and glucose infusion on myocardial infarction size in uraemic rats. Basic Res Cardiol (2009) 0.79
Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells. Pediatr Nephrol (2012) 0.79
Prognostic value of standard parameters as predictors for long-term renal replacement therapy after liver transplantation. Nephron Clin Pract (2011) 0.79
Pharmacokinetics of 5-fluorouracil and its catabolites determined by 19F nuclear magnetic resonance spectroscopy for a patient on chronic hemodialysis. Am J Kidney Dis (2002) 0.79
Deciphering the systems biology of mTOR inhibition by integrative transcriptome analysis. Curr Pharm Des (2014) 0.78
Plasmapheresis adjusts inflammatory responses in potential kidney transplant recipients. Transplantation (2013) 0.78
A nephrotic patient with tumour necrosis factor receptor-associated periodic syndrome, IgA nephropathy and CNS involvement. Nephrol Dial Transplant (2006) 0.78
The patient with C-ANCA/PR3-ANCA-positive crescentic pauci-immune glomerulonephritis and recurrence of nephritic sediment. Nephrol Dial Transplant (2008) 0.77
Cellular infiltrates and NFκB subunit c-Rel signaling in kidney allografts of patients with clinical operational tolerance. Transplantation (2012) 0.77
Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft. Transplantation (2005) 0.77
The receptor for advanced glycation end-products (RAGE) plays a key role in the formation of nanotubes (NTs) between peritoneal mesothelial cells and in murine kidneys. Cell Tissue Res (2014) 0.77
Intestinal transplantation: review of operative techniques. Clin Transplant (2013) 0.77
Psychosocial and physical outcome following kidney donation-a retrospective analysis. Transpl Int (2015) 0.77
Proteinuria and sirolimus after renal transplantation: a retrospective analysis from a large German multicenter database. Clin Transplant (2013) 0.77
daf-16/FOXO and glod-4/glyoxalase-1 are required for the life-prolonging effect of human insulin under high glucose conditions in Caenorhabditis elegans. Diabetologia (2014) 0.77